Prevention of venous thromboembolism in medical patients and outpatients.
The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, controlled trials evaluating the safety and efficacy of pharmacologic venous thromboembolism (VTE) prophylaxis in medical patients, now recommend using VTE prophylaxis in this population. Unfortunately, prophylaxis rates in medical patients are unacceptably low, despite efforts to develop strategies for improving implementation of prophylaxis regimens. Studies indicate that a substantial proportion of patients with VTE present after hospital discharge, but no clinical trials evaluating VTE prophylaxis for medical outpatients have yet been published. In this Review, we examine the literature on VTE prophylaxis in hospitalized medical patients, and evaluate the available data for the outpatient setting.
Stashenko
Gregg J
GJ
Division of Pulmonary and Critical Care, Duke University Medical Center, Box 31175, Room 351 Bell Building, Durham, NC 27710, USA. gregg.stashenko@duke.edu
Tapson
Victor F
VF
D000925:Anticoagulants / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D019983:Guideline Adherence; D006801:Humans; D007297:Inpatients; D010045:Outpatients; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants